Skip to main content
. 2021 Dec 8;8:764909. doi: 10.3389/fvets.2021.764909

Figure 6.

Figure 6

Stage of antiviral activity against cpBVDV C24V by ginsenoside Rb2 and Rb3. (A) A schematic diagram describing the experimental scheme for measuring the stage at which ginsenoside exerts its effects. (B) The FA result of plaque reduction assays. (C) Changes in viral RNA level. *p < 0.05; ***p < 0.001.